Long-term anti-FVIII antibody response in Bethesda-negative haemophilia A patients receiving continuous replacement therapy

British Journal of Haematology

Volumn 163, Issue 3, 2013, Pages 385-392

  Klintman, Jenny ^a   Hillarp, Andreas ^b   Berntorp, Erik ^a   Astermark, Jan ^a  

^a Haematology and Coagulation Disorders   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Clotting factors; Factor VIII; Haemophilia A; Immunogenicity; Non neutralizing anti FVIII antibodies

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 ANTIBODY; BLOOD CLOTTING FACTOR 8 CONCENTRATE; NEUTRALIZING ANTIBODY; NON NEUTRALIZING ANTIBODY; RECOMBINANT BLOOD CLOTTING FACTOR 8; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; AMINO ACID SUBSTITUTION; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; BETHESDA ASSAY; BIOASSAY; BLEEDING; CATHETERIZATION; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG RESPONSE; F8 GENE; FEMALE; HEMOPHILIA A; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; SUBSTITUTION THERAPY;

CLOTTING FACTORS; FACTOR VIII; HAEMOPHILIA A; IMMUNOGENICITY; NON-NEUTRALIZING ANTI-FVIII ANTIBODIES;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FACTOR VIII; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HEMOPHILIA A; HEMORRHAGE; HUMANS; INFANT; ISOANTIBODIES; MALE; MIDDLE AGED; NEUTRALIZATION TESTS; PROTEIN STRUCTURE, TERTIARY; YOUNG ADULT;

EID: 84885423738     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12540     Document Type: Article

References (25)

1. Arbuckle, M.R., McClain, M.T., Rubertone, M.V., Scofield, R.H., Dennis, G.J., James, J.A. & Harley, J.B. (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. New England Journal of Medicine, 349, 1526-1533.
2. Batlle, J., Gomez, E., Rendal, E., Torea, J., Loures, E., Couselo, M., Vila, P., Sedano, C., Tusell, X., Magallon, M., Quintana, M., Gonzalez-Boullosa, R. & Lopez-Fernandez, M.F. (1996) Antibodies to factor VIII in plasma of patients with hemophilia A and normal subjects. Annals of Hematology, 72, 321-326.
3. Castenskiold, E.C., Colvin, B.T. & Kelsey, S.M. (1994) Acquired factor VIII inhibitor associated with chronic interferon-alpha therapy in a patient with haemophilia A. British Journal of Haematology, 87, 434-436.
4. Dazzi, F., Tison, T., Vianello, F., Radossi, P., Zerbinati, P., Carraro, P., Poletti, A. & Girolami, A. (1996) High incidence of anti-FVIII antibodies against non-coagulant epitopes in haemophilia A patients: a possible role for the half-life of transfused FVIII. British Journal of Haematology, 93, 688-693.
5. DiMichele, D.M. (2013) Inhibitors in childhood hemophilia A: genetic and treatment-related risk factors for development and eradication. Pediatric Blood & Cancer, 60, S30-S33.
6. Gilles, J.G., Arnout, J., Vermylen, J. & Saint-Remy, J.M. (1993) Anti-factor VIII antibodies of hemophiliac patients are frequently directed towards nonfunctional determinants and do not exhibit isotypic restriction. Blood, 82, 2452-2461.
7. Kasper, C.K. & Pool, J.G. (1975) Measurement of mild factor VIII inhibitors in Bethesda units. Thrombosis et Diathesis Haemorrhagica, 34, 875-876.
8. Kasper, C.K., Aledort, L., Aronson, D., Counts, R., Edson, J.R., van Eys, J., Fratantoni, J., Green, D., Hampton, J., Hilgartner, M., Levine, P., Lazerson, J., McMillan, C., Penner, J., Shapiro, S. & Shulman, N.R. (1975) A more uniform measurement of factor VIII inhibitors. Thrombosis et Diathesis Haemorrhagica, 34, 612.
9. Kempton, C.L., Meeks, S.L., Donald Harvey, R. & Abshire, T.C. (2011) Evaluation of factor VIII pharmacokinetics and anti-factor VIII antibodies in four boys with haemophilia A and a poor clinical response to factor VIII. Haemophilia, 17, 155-156.
10. Klintman, J., Hillarp, A., Donfield, S., Berntorp, E. & Astermark, J. (2013) Antibody formation and specificity in Bethesda-negative brother pairs with haemophilia A. Haemophilia, 19, 106-112.
11. Knobe, K.E., Sjörin, E., Tengborn, L.I., Petrini, P. & Ljung, R.C.R. (2002) Inhibitors in the Swedish population with severe haemophilia A and B: a 20-year survey. Acta Paediatrica, 91, 910-914.
12. Krudysz-Amblo, J., Parhami-Seren, B., Butenas, S., Brummel-Ziedins, K.E., Gomperts, E.D., Rivard, G.E. & Mann, K.G. (2009) Quantitation of anti-factor VIII antibodies in human plasma. Blood, 113, 2587-2594.
13. Lebreton, A., Lapalud, P., Chambost, H., Biron-Andreani, C., Morange, P.E., Combescure, C., Marques-Verdier, A., Berger, C., Schved, J.F., Granier, C. & Lavigne-Lissalde, G. (2011) Prevalence and epitope specificity of non-neutralising antibodies in a large cohort of haemophilia A patients without inhibitors. Thrombosis and Haemostasis, 105, 954-961.
14. Ling, M., Duncan, E.M., Rodgers, S.E., Street, A.M. & Lloyd, J.V. (2003) Low detection rate of antibodies to non-functional epitopes on factor VIII in patients with hemophilia A and negative for inhibitors by Bethesda assay. Journal of Thrombosis and Haemostasis, 1, 2548-2553.
15. Mondorf, W., Klinge, J., Luban, N.L., Bray, G., Saenko, E. & Scandella, D. (2001) Low factor VIII recovery in haemophilia A patients without inhibitor titre is not due to the presence of anti-factor VIII antibodies undetectable by the Bethesda assay. Haemophilia, 7, 13-19.
16. Recke, A., Rose, C., Schmidt, E., Brocker, E.B., Zillikens, D. & Sitaru, C. (2009) Transition from pemphigus foliaceus to bullous pemphigoid: intermolecular B-cell epitope spreading without IgG subclass shifting. Journal of American Academy of Dermatology, 61, 333-336.
17. Scandella, D., Mondorf, W. & Klinge, J. (1998) The natural history of the immune response to exogenous factor VIII in severe haemophilia A. Haemophilia, 4, 546-551.
18. Takeyama, M., Nogami, K., Matsumoto, T. & Soeda, T. (2009) Characterisation of an antibody specific for coagulation factor VIII that enhances factor VIII activity. Thrombosis and Haemostasis., 103, 94-102.
19. Takeyama, M., Nogami, K., Matsumoto, T., Soeda, T., Suzuki, T., Hattori, K. & Shima, M. (2010) Characterisation of an antibody specific for coagulation factor VIII that enhances factor VIII activity. Thrombosis and Haemostasis, 103, 94-102.
20. Verbruggen, B., Novakova, I., Wessels, H., Boezeman, J., van den Berg, M. & Mauser-Bunschoten, E. (1995) The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability. Thrombosis and Haemostasis, 73, 247-251.
21. Vianello, F., Radossi, P., Tison, T., Dazzi, F., Tagariello, G., Davoli, P.G. & Girolami, A. (1997) Prevalence of anti-FVIII antibodies in severe haemophilia A patients with inversion of intron 22. British Journal of Haematology, 97, 807-809.
22. Vincent, A.M., Lillicrap, D., Boulanger, A., Meilleur, C., Amesse, C., St-Louis, J. & Rivard, G.E. (2009) Non-neutralizing anti-FVIII antibodies: different binding specificity to different recombinant FVIII concentrates. Haemophilia, 15, 374-376.
23. Waseem, N.H. (1999) Start of UK confidential haemophilia A database: analysis of 142 patients by solid phase fluorescent chemical cleavage of mismatch. Thrombosis and haemostasis, 81, 900-905.
24. van der Woude, D., Rantapaa-Dahlqvist, S., Ioan-Facsinay, A., Onnekink, C., Schwarte, C.M., Verpoort, K.N., Drijfhout, J.W., Huizinga, T.W., Toes, R.E. & Pruijn, G.J. (2010) Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis. Annals of Rheumatic Diseases, 69, 1554-1561.
25. Zakarija, A., Harris, S., Rademaker, A.W., Brewer, J., Krudysz-Amblo, J., Butenas, S., Mann, K.G. & Green, D. (2011) Alloantibodies to factor VIII in haemophilia. Haemophilia, 17, 636-640.